http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HR-P20110716-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6d6b0a9721d7b7ca7d5f368df0f3658
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-08
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-56
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
filingDate 2011-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c97046168129b5c4c0ab87bc53619467
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d9c4e0e867d86f98796627599018d21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a94d6135b3b70d0a826c9648489889f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de1dfad6b8de6dbde9dca9557628359e
publicationDate 2011-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HR-P20110716-T1
titleOfInvention ARIL DICARBOXAMID
abstract The use of aryl dicarboxamide according to formula (I): as well as its geometric isomers, its optically active forms as enantiomers, as, diastereomers and its racemic forms, indicated that A is an aminocarbonyl group according to the formula -CO-NHR6 where R6 is substituted or unsubstituted C6 -C15 alkyl, substituted or unsubstituted C2-C15-alkenyl, substituted or unsubstituted C2-C15-alkynyl, substituted or unsubstituted 3-8 membered cycloalkyl, substituted or unsubstituted C1-C6 alkyl-(3-8 membered) cycloalkyl, substituted or unsubstituted phenyl, substituted or unsubstituted C1-C12 alkyl phenyl, substituted or unsubstituted C2-C6 alkenyl phenyl, substituted or unsubstituted C2-C6 alkynyl phenyl; Cy is substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted aryl-heteroaryl, substituted or unsubstituted heteroaryl-aryl, substituted or unsubstituted aryl-aryl, substituted or unsubstituted cycloalkyl or substituted or unsubstituted heterocyclic group; n was either 0 or 1; R1 and R2 are independently selected from the group consisting of hydrogen or substituted or unsubstituted C1-C6-alkyl; R 3 is selected from the group consisting of substituted or unsubstituted C 1 -C 6 -alkyl, substituted or unsubstituted C 2 -C 6 -alkenyl, substituted or unsubstituted C 2 -C 6 -alkynyl, substituted or unsubstituted C 1 -C 6 -alkyl, substituted or unsubstituted C 1 -C 6 - alkyl amine, substituted or unsubstituted C1-C6-alkyl alkoxy, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted saturated or unsaturated 3-8-membered cycloalkyl, substituted or unsubstituted 3-8-membered heterocycloalkyl, substituted or unsubstituted C1 -C6-alkyl aryl, substituted or unsubstituted C1-C6-alkyl heteroaryl, substituted or unsubstituted C2-C6-alkenyl aryl, substituted or unsubstituted C2-C6-alkenyl heteroaryl, substituted or unsubstituted C2-C6-alkynyl aryl, substituted or unsubstituted C2 -C6-alkynyl heteroaryl, substituted or unsubstituted C1-C6-alkyl cycloalkyl, substituted or unsubstituted C1-C6-alkyl heterocycloalkyl, substituted an or unsubstituted C2-C6-alkenyl cycloalkyl, substituted or unsubstituted C2-C6-alkenyl heterocycloalkyl, substituted or unsubstituted C2-C6-alkynyl cycloalkyl, substituted or unsubstituted C2-C6-alkynyl heterocycloalkyl; R4 and R5 are independently selected from the group consisting of H, hydroxy, substituted or unsubstituted C1-C6 alkyl, carboxy, substituted or unsubstituted C1-C6 alkoxy, substituted or unsubstituted C1-C3 alkyl carboxy, substituted or unsubstituted C2-C3 alkenylcarboxy, substituted or unsubstituted C2-C3 alkynylcarboxy, amino or R4 and R5 may form an unsaturated or saturated heterocyclic ring, wherein at least one of R4 or R5 is not hydrogen or C1-C6 alkyl; wherein the above-mentioned groups, when substituted, are substituted
priorityDate 2003-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310

Total number of triples: 40.